Rare gain-of-function mutations within the ITGA2B or ITGB3 genes have been recognized to cause macrothrombocytopenia (MTP). Here we report three new families with autosomal dominant (AD) MTP, two harboring the same mutation of ITGA2B, aIIbR995W, and a third family with an ITGB3 mutation, b3D723H. In silico analysis shows how the two mutated amino acids directly modify the salt bridge linking the intra-cytoplasmic part of aIIb to b3 of the integrin aIIbb3. For all affected patients, the bleeding syndrome and MTP was mild to moderate. Platelet aggregation tended to be reduced but not absent. Electron microscopy associated with a morphometric analysis revealed large round platelets; a feature being the presence of abnormal large a-granules with some giant forms showing signs of fusion. Analysis of the maturation and development of megakaryocytes reveal no defect in their early maturation but abnormal proplatelet formation was observed with increased size of the tips. Interestingly, this study revealed that in addition to the classical phenotype of patients with aIIbb3 intracytoplasmic mutations there is an abnormal maturation of a-granules. It is now necessary to determine if this feature is a characteristic of all mutations disturbing the aIIb R995/b3 D723 salt bridge.
| I N TR ODU C TI ON
Integrin aIIbb3 is the platelet receptor for fibrinogen (Fg) and other adhesive proteins and mediates platelet aggregation playing a key role in hemostasis and thrombosis. It circulates on platelets in a low-affinity state becoming ligand-competent as a result of conformational changes induced by "inside-out" signaling following platelet activation. 1 Inherited defects of aIIbb3 with loss of expression and/or function are causal of Glanzmann thrombasthenia (GT), an autosomal recessive bleeding disorder. 2, 3 Rare gain-of-function mutations of the ITGA2B or ITGB3 genes encoding aIIbb3 also cause macrothrombocytopenia (MTP) with a low platelet count and platelets of increased size. 3, 4 Mostly heterozygous with autosomal dominant (AD) expression these include D621_E660del*, L718P, L718del and D723H mutations in b3, and G991C, G993del, R995Q or W in aIIb (Supporting Information   Table S1 ). [5] [6] [7] [8] [9] [10] [11] [12] While D621_E660del affects the extracellular cysteinerich bA domain of b3, the others affect transmembrane or intracellular cytoplasmic domains and in particular the salt bridge linking the negatively charged D723 of b3 with the positively charged R995 of the much studied GFFKR sequence of aIIb. [13] [14] [15] These mutations permit residual or even total aIIbb3 expression but give rise to conformation changes that propagate through the integrin and which are recognized by binding of the monoclonal antibody, PAC-1. 16 The MTP appears *Human Genome Variation Society nomenclature for the aIIb and b3 mature proteins are used in this study. 
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related to cytoskeletal changes during the late stages of megakaryocyte (MK) development and altered proplatelet formation. [17] [18] [19] Yet, while most of the above variants combine MTP with a substantial loss of platelet aggregation and a GT-like phenotype, the b3D723H substitution had no effect on platelet aggregation and was called a nonsynonymous single nucleotide polymorphism (SNP) by the authors. 7 This was surprising as another cytoplasmic domain mutation involving a near-neighbor Arg724Ter truncating mutation in b3, while not preventing aIIbb3 expression gave a full GT phenotype. 20 We recently reported a heterozygous intracytoplasmic b3 Leu718del that resulted in loss of synchronization between the cytoplasmic tails of b3 and aIIb; changes that gave moderate MTP, a reduced platelet aggregation response and, unexpectedly, enlarged a-granules. 12 It is in this context that we now report our studies on a second European family with a heterozygous b3D723H variant as well as the first two families to be described outside of Japan with a heterozygous aIIbR995W substitution. Significantly, not only both of these variants of the aIIbR995/b3D723 salt bridge give rise to moderate MTP and platelet function defects; their platelets also contained enlarged a-granules.
| C ASE H I STOR IES
We now report three families (A from Reunion island; B and C from France) with non-syndromic inherited MTP transmitted across 2 or 3 generations suggestive of autosomal dominant (AD) inheritance. The family pedigrees are shown in Figure 1 and the three index cases (AII.1 an adult female, BI.1 and CI.1 adult males) identified. Other family members known to have MTP and significant subpopulations of enlarged platelets are also highlighted. All showed moderate to mild thrombocytopenia and often a higher proportion of immature platelets when analyzed with the Sysmex XE-5000 automat (Sysmex,Villepinte, France) although we recognize that the large size of the patients' platelets may lead to an over-estimation (Supporting Information Table S2 ).
Increased mean platelet volumes were observed for BI.1, CI.1, and C1.2 (Supporting Information Table S2 ); values are not given when the large diameter of many of the platelets prevented an accurate estimation by the automatic blood cell analyzer (particularly so for members of family A with MTP). Other blood cell lineages were usually present for affected family members and all routinely tested coagulation parameters were normal. As quantitated by the ISTH-BAT bleeding score, members of family A with MTP were the most affected (Supporting Information Table S2 ). For example, AII.1 suffered from severe menorrhagia and severe post-partum bleeding requiring platelet and red blood cell transfusions after her second childbirth although two other children were born without problems (including a cesarean section).
AII.1 also experienced occasional spontaneous bruising and episodes of iron-deficient anemia of unknown cause. An affected sister also has easy bruising and childbirth was under the cover of platelet transfusion.
In family B the index case BI. 
| Flow cytometric analysis (FCM)
Glycoprotein expression on unstimulated platelets was assessed using citrated PRP according to our standard protocols. 12, 21 On occasion, platelet surface labeling for aIIb, b3, GPIba and P-selectin was quantified using the PLT Gp/Receptors kit (Biocytex, Marseille, France) at room temperature before and after stimulation with 10 mM ADP and 50 mM 
| Transmission electron microscopy (EM)
PRP from blood taken into citrate or ACDA anticoagulant was diluted and fixed in PBS, pH 7.2, containing 1.25%(v/v) glutaraldehyde for 1 h as described. 12 After centrifugation and two PBS washings, they were As illustrated for AII.1 and BI.1, a C-to-T transition at nucleotide 3076 (3076C > T), changing R995 to W for ITGA2B, and for CI.1 a G-to-C transition at nucleotide 2254 (2254G > C) changing D723 to H for ITGB3, were detected. A vertical arrow shows the position of the substitution on the sequencing histograms. The penetrance of the mutation within each family is shown on each pedigree (1/-). In the lower panel, cartoons obtained through in silico PyMOL modeling show how aIIbR995W and b3D723H influence interactions between the transmembrane and cytoplasmic domains. The first relates to W713 of b3 and F992 and F993 of aIIb. This association motif consists of p interactions and aromatic cycle stacking. Two other well conserved motifs (GFFKR and HDR(R/K)E for aIIb and b3, respectively) localize close to the cytoplasmic face of the membrane with the formation of a salt bridge involving the positively charged R995 of aIIb and the negatively charged D723 of b3. 25 In the cartoon, aIIb is in blue while b3 is in green; aromatic amino acids involved in p interactions are shown as sticks and transparent spheres. The salt bridge is represented as dashed circles, with the positive aIIb-R995 and the negative b3-D723 as sticks. The graphical "bumps" (red discs) reveal steric encumbrance caused by the amino acid substitution. The D723H mutation (family C) results in the replacement of the negatively charged D by the positively charged and larger H. The overall potential effect of repulsive charges and steric encumbrance promote separation of the two transmembrane segments. Similar but less extensive changes are seen when Arg995 is substituted with the neutral W [Color figure can be viewed at wileyonlinelibrary.com] France). Morphometric measurements were made using Image J software (National Institutes of Health, USA). In silico models to investigate aIIbb3 structural changes induced by the mutations were obtained using the PyMOL Molecular Graphics System, version 1.3, Schr€ odinger, LLC (www.pymol.org) and 2k9j pdb files for transmembrane and cytosolic domains as described in our previous publications. 3, 4, 12 Amino acid changes are visualized in the rotamer form showing side change orientations incorporated from the Dunbrack Backbone library with maximum probability.
| Genetic analysis and mutation screening

| In vitro MK differentiation, ploidy analyses, quantification of proplatelets and immunofluorescence analysis
Plasma thrombopoietin (TPO) levels were measured as previously described. 21 Patient or control CD34 1 cells were isolated using an immunomagnetic beads technique (Miltenyi, Biotec, France) and grown supplemented with 10 ng/mL TPO (Kirin Brewery, Tokyo, Japan) and 25 ng/mL Stem Cell Factor (SCF; Biovitrum AB, Stockholm, Sweden).
| Ploidy analyses
At day For AII.1 aggregation intensity was low and that with high doses of TRAP was particularly reduced compared to ristocetin-induced platelet agglutination whose intensity may reflect the low platelet count of the patient. For BI.1 platelet aggregation was moderately reduced with Col and TRAP while for CI.1 platelet aggregation was reduced essentially for TRAP and AA (it should be noted that it was restored with the thromboxane receptor agonist U46619, not shown). In B) Spontaneous PAC1 binding evaluated by flow cytometry on resting platelets was marginally increased for AII.1 but not for the other index cases. Binding increased for AII.1 after platelet activation with ADP and TRAP but remained low compared to the control. In contrast, PAC-1 binding was basal for BI.1 and CI.1 even after addition of ADP or TRAP. In C) we illustrate the levels of GPIb and aIIbb3 receptors evaluated by flow cytometry not only for the probands but also for other selected family members. A decreased surface expression was found for aIIbb3 for all affected patients, values ranging between 0.48 for AII.2 and 0.75 (BII.2) of the control mean. Interestingly, levels of GPIb were increased for the patients and particularly so for families A and B with sometimes values beyond 150% of normal values [Color figure can be viewed at wileyonlinelibrary.com] FAVIER ET AL.
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second family with this mutation or for the index case of the family with b3D723H ( Figure 2C ). Studies were extended to platelets stimulated with high doses of ADP and TRAP; increased binding was seen for AII.1 consistent with further activation of the residual surface aIIbb3 of the platelets. However, no binding was seen for BI.1 or C.I.1. suggesting that for these patients the residual aIIbb3 was refractory to stimulation under the non-stirred conditions of this set of experiments ( Figure 2B ).
| Electron microscopy
Platelets from the index cases of all 3 families were examined by transmission EM and for each subject a significant subpopulation of the platelets were larger than normal (Figure 3 ). In total, 63% of platelets for AII.1, 64% for BI.1 and 49% for CI.1 exhibit a surface area >4 mm 2 , (control platelets: 22 6 6%) and 16% for AII.1, 21% for BI.1 and 12%
for CI.1 exhibit a large diameter >4 mm (control platelets 3 6 1%), values obtained from 100 platelet sections. The platelets showed wide size variations; many tended to be round in contrast to the discoid shape of controls as illustrated in Figure 3 . A round shape is confirmed by the higher proportion of platelets with a ratio (larger diameter/small diameter) < 1.5: 61% for AII.1, 35% for BI.1, 31% for CI.1 (normal platelets: 17 6 2%).
Platelets from the index cases also showed increased but variable numbers of vacuoles. This was accompanied by a more heterogeneous distribution of a-granules and striking was the presence of giant forms particularly evident for patient AII.1. The giant granules may also be seen on May-Gr€ unweld-Giemsa-stained peripheral blood smears (Supporting Information Figure S1 ); the coalescent aspect of granules detected by EM is highly suggestive of a fusion phenomenon (highlighted in Figure 3 
| Megakaryopoiesis
Plasma TPO levels were within normal range for each of the index cases (Supporting Information Table S2 
| D ISC USSION
In the resting state, the trans-membrane and intra-cytoplasmic segments of the two subunits of aIIbb3 interact, an interaction that is key to maintaining the extracellular domain of the integrin in its bent resting state. 15, 25 One area of contact between the cytoplasmic tails involves p interactions and aromatic cycle stacking of consecutive F residues within the highly conserved aIIb GFFKR (aa991-955) sequence with W713 of b3 (shown in Figure 1C) . A second interaction principally involves a salt bridge between the positively charged aIIbR995 and negatively charged b3D723. [13] [14] [15] Early studies including site-directed mutagenesis, truncation models and charge reversal mutations showed that loss of this intra-molecular clasp led to integrin activation and modified function. 13, 14 Hence the mutations described in our patients are of high significance for integrin biology. Enigmatically, the b3D723H change has the more pronounced structural effect resulting in (i) repulsive electrical charge forces with the positively charged H now facing the positively charged R995 and (ii) steric encumbrance due to the larger H. The net result is a widening of the interval between R995 and H723 and a weakening of the salt bridge, changes that accompany the acquisition of a higher affinity state. 26 Of similar consequence but milder in nature is the replacement of aIIbR995 by the neutral W while both mutations potentially also interfere with p interactions involving aIIbF992.
A novel feature of our study is the presence of enlarged a-granules in the platelets of all 3 index cases. This is of interest for we have recently reported enlarged a-granules for a patient with MTP associated with a b3 L718del resulting in loss of synchronization between opposing amino acids of the aIIb and b3 cytoplasmic tails and a weakening of the aIIbR995/b3D723 salt bridge (Supporting Information Table S1 ). 12 The presence of enlarged a-granules in platelets of patients from 3 unrelated families with MTP linked to cytoplasmic tail mutations in ITGA2B or ITGB3 in our current study strongly suggests that they have a role in the ultrastructural changes with emphasis on the aIIbR995W mutation. But further studies will be required to define Noris et al. 29 who measured platelet diameters in patients with MTP associated with ITGB3 and ITGA2B defects using an automated cell counter. Inheritance is AD for previously reported cases when family studies permit this conclusion, although two reports associate single allele missense mutations of the aIIb cytoplasmic tail with a second and different mutation causing loss of expression of the second allele. 6, 10 Such a loss may exaggerate the effect of single allele missense mutations in these cases. In all but one of the published cases bleeding was mild to moderate or was absent and our cases follow this pattern.
Nonetheless, management of such patients in the event of hemostatic challenge is a major problem and the risk of bleeding during surgery caused by a low platelet count and abnormalities of platelet function should always be taken into account. Platelet aggregation in our families was never totally abrogated but tended to occur more slowly with a reduced final intensity. Strikingly, it was variable between agonists and although it is tempting to use the ristocetin-induced agglutination as a control for the low platelet count, the unknown effect of the combination of elevated GPIb and low aIIbb3 urges prudence. Interestingly, with the exception of the response to AA, platelets of family C (b3D723H) retained the best aggregation profile, a finding in agreement with the report on the UK family with the same mutation. 7 For all of our index cases, intermediate levels of aIIbb3 were present at the surface, results again consistent with many of the literature reports (Supporting Information Table S1 ). It is noteworthy that the platelet aggregation response of obligate heterozygotes for classic type I
GT is normal 2 suggesting that despite the influence of the low platelet count, the cytoplasmic domain mutations have a direct effect on the platelet aggregation response. Interestingly, a low platelet surface aIIbb3 expression was shown to be associated with normal internal pools of aIIbb3 in patients with aIIbR995Q and aIIbR99W substitutions suggesting defects in integrin recycling. 5, 10 Our results for family C with intermediate platelet surface levels of aIIbb3 differed from the results for the UK family where aIIbb3 expression was normal. 7 Expression of the adhesion receptor GPIb was increased on the platelets of our index cases and especially so for the two with the aIIbR995W variant a finding that was previously also observed for Japanese cases with the same mutation. 9 The reason for this increase is not known but it could reflect the increase in platelet volume and also an altered megakaryopoiesis.
A feature of aIIb or b3 cytoplasmic domain mutations causal of MTP is that long-range conformational changes extend to the functional domains of the integrin and give what is often termed a partially activated state [6] [7] [8] [9] [10] [11] [12] (Supporting Information Table S1 ). This was confirmed by Hughes et al. 13, 14 who expressed aIIbb3 in CHO cells after modifying residues of the salt bridge through site-directed mutagenesis. While the changes permit binding of the activation-dependent IgM
MoAb PAC-1, only for one report has spontaneous binding of Fg been observed for this class of mutation. 11 Such results therefore differ from the C560R mutation in the b3 cysteine-rich b (A) extracellular domain as reported for a French patient whose platelets circulated with aIIbb3-bound Fg. 30 The conformational changes permitting spontaneous PAC-1 binding but only rarely Fg binding remain to be defined although aIIbb3 clustering remains a potential explanation. 8 The activation state of aIIbb3 is also often greater in transfected heterol- ship between defects in aIIbb3 complexes to changes in a-granule size remains to be determined. VWF-labelled granules of increased size were detected already in proplatelets in AII.1 and interestingly for the three patients studied, the larger the platelet surface area the larger the a-granule diameter suggesting that the defect responsible for increased platelet size contributes also to the determination of a-granule size. The cause of the apparent fusion or coalescing of granules as a mechanism of forming the giant granules not only observed for this patient but also for the b3 Leu718 deletion 12 merits further study. The fact that all of the above mutations modify the salt bridge between the positively charged aIIbR995 and negatively charged b3D723 is particularly intriguing.
Our results therefore support a generalized hypothesis where mutations within aIIb or b3 cytoplasmic domains somehow lead to a facilitated MK surface interaction with stromal proteins in the marrow medullary compartment that in turn promote cytoskeletal changes that not only lead to altered proplatelet formation and platelet biogenesis but also, at least on occasion, an altered a-granule maturation.
